Antineoplastic-Agents-Hormonal

03/02/2010

Pivotal Advance: Heme oxygenase 1 expression by human CD4+ T cells is not sufficient for their development of immunoregulatory capacity. (Antineoplastic-Agents-Hormonal)

03/02/2010

A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD. (Antineoplastic-Agents-Hormonal)

03/02/2010

Mycotic carotid pseudoaneurysm: staged endovascular and surgical repair. (Antineoplastic-Agents-Hormonal)

03/02/2010

Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. (Antineoplastic-Agents-Hormonal)

03/02/2010

Alogliptin use in elderly people: a pooled analysis from phase 2 and 3 studies. (Antineoplastic-Agents-Hormonal)

03/02/2010

Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system. (Antineoplastic-Agents-Hormonal)

03/02/2010

Human immunodeficiency virus in an aging population, a complication of success. (Antineoplastic-Agents-Hormonal)

03/02/2010

Prediction of cardiorespiratory fitness in older men infected with the human immunodeficiency virus: clinical factors and value of the six-minute walk distance. (Antineoplastic-Agents-Hormonal)

03/02/2010

Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over time. (Antineoplastic-Agents-Hormonal)

01/02/2010

An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. (Antineoplastic-Agents-Hormonal)